secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001493152-24-036548
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab doubles assessment completions to ~50K year-to-date; two abstracts accepted at ACAAI
--------------------------------------------------------------------------------

- Platform processed ~50,000 assessments in 2024 YTD, more than double the same period in 2023.
- Two abstracts accepted for presentation at ACAAI conference in Boston; two more submitted for 2025 APA meeting.
- R&D focusing on AI-driven digital tools for allergic rhinitis, anxiety, depression, chronic pain.
- Preliminary findings from health journeys series show reduced depression, anxiety, pain, allergy scores after few months.
- Company continues to integrate digital medicine to reduce non-clinical burden on providers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315224036548/0001493152-24-036548-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315224036548/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036548

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer